|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000108509 |
Summary for CAMTA2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000108509 | Gene symbol | CAMTA2 |
| Gene name | calmodulin binding transcription activator 2 | |
| HGNC | 18807 | |
| Entrez ID | 23125 | |
| Gene type | protein_coding | |
| Synonyms | CAMTA2|KIAA0909 | |
| UniProtAcc | O94983 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CAMTA2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CAMTA2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CAMTA2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg18993757 | chr17:4986459 | CGI:chr17:4986987-4987696 | promoter,gene body | 2.47e-01 | 4.07e-01 | -4.06e+00 | 4.99e-05 | 3.51e-04 | -1.60e-01 |
| ACC | cg19427746 | chr17:4986637 | CGI:chr17:4986987-4987696 | promoter,gene body | 1.98e-01 | 3.40e-01 | -2.84e+00 | 4.49e-03 | 1.60e-02 | -1.42e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg14928057 | chr17:4988247 | CGI:chr17:4986987-4987696 | promoter | 2.14e-01 | 3.77e-02 | 3.14e+00 | 1.71e-03 | 3.74e-03 | 1.76e-01 |
| LUSC | cg19427746 | chr17:4986637 | CGI:chr17:4986987-4987696 | promoter,gene body | 3.37e-01 | 2.07e-01 | 2.84e+00 | 4.51e-03 | 7.55e-03 | 1.30e-01 |
| COAD | cg14928057 | chr17:4988247 | CGI:chr17:4986987-4987696 | promoter | 4.95e-01 | 2.66e-01 | 3.56e+00 | 3.78e-04 | 1.02e-03 | 2.29e-01 |
| COAD | cg25349574 | chr17:4987996 | CGI:chr17:4986987-4987696 | promoter | 2.01e-01 | 7.88e-02 | 2.91e+00 | 3.56e-03 | 6.28e-03 | 1.22e-01 |
| LIHC | cg14928057 | chr17:4988247 | CGI:chr17:4986987-4987696 | promoter | 5.60e-01 | 4.07e-01 | 3.48e+00 | 5.01e-04 | 8.58e-04 | 1.53e-01 |
| KIRP | cg15100135 | chr17:4988480 | CGI:chr17:4986987-4987696 | promoter | 4.59e-01 | 3.20e-01 | 3.60e+00 | 3.24e-04 | 7.01e-04 | 1.39e-01 |
| ESCA | cg14928057 | chr17:4988247 | CGI:chr17:4986987-4987696 | promoter | 2.47e-01 | 6.26e-02 | 2.09e+00 | 3.62e-02 | 4.56e-02 | 1.84e-01 |
| CHOL | cg18993757 | chr17:4986459 | CGI:chr17:4986987-4987696 | promoter,gene body | 3.04e-01 | 4.89e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -1.85e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14928057 | chr17:4988247 | CGI:chr17:4986987-4987696 | promoter | 2.41e-01 | 4.58e-02 | 1.06e+01 | 2.36e-26 | 2.29e-25 | 1.95e-01 |
| LUAD | cg19427746 | chr17:4986637 | CGI:chr17:4986987-4987696 | promoter,gene body | 3.12e-01 | 2.05e-01 | 2.35e+00 | 1.90e-02 | 2.49e-02 | 1.07e-01 |
| BLCA | cg15100135 | chr17:4988480 | CGI:chr17:4986987-4987696 | promoter | 3.01e-01 | 1.67e-01 | 2.73e+00 | 6.29e-03 | 1.31e-02 | 1.33e-01 |
| LIHC | cg19427746 | chr17:4986637 | CGI:chr17:4986987-4987696 | promoter,gene body | 4.16e-01 | 2.32e-01 | 3.90e+00 | 9.54e-05 | 3.71e-04 | 1.85e-01 |
| LIHC | cg25349574 | chr17:4987996 | CGI:chr17:4986987-4987696 | promoter | 1.97e-01 | 9.00e-02 | 3.39e+00 | 7.05e-04 | 1.72e-03 | 1.07e-01 |
Top |
Exon skipping events with PSI in TCGA for CAMTA2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CAMTA2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CAMTA2 |
| TFs related to CAMTA2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CAMTA2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CAMTA2 |
| RBPs related to ES in CAMTA2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | STAR-PAP | exon_skip_285854 | 1.43e+01 | 9.99e-01 | 1.36e+01 | 1.20e-03 | Male-biased |
| UVM | STAR-PAP | exon_skip_285854 | 1.41e+01 | 2.83e-04 | 1.47e+01 | 1.00e+00 | Female-biased |
| THYM | STAR-PAP | exon_skip_285854 | 1.41e+01 | 6.64e-04 | 1.47e+01 | 9.99e-01 | Female-biased |
| COAD | HNRNPH2 | exon_skip_285882 | 6.52e+00 | 2.49e-03 | 6.99e+00 | 9.84e-01 | Female-biased |
| COAD | STAR-PAP | exon_skip_285854 | 1.44e+01 | 9.99e-01 | 1.38e+01 | 8.64e-04 | Male-biased |
| DLBC | RBM6 | exon_skip_285847 | 9.57e+00 | 1.52e-02 | 9.87e+00 | 9.82e-01 | Female-biased |
| BRCA | ZC3H10 | exon_skip_285873 | 7.24e+00 | 4.69e-03 | 8.09e+00 | 9.87e-01 | Female-biased |
| ESCA | STAR-PAP | exon_skip_285854 | 1.36e+01 | 3.19e-03 | 1.42e+01 | 9.97e-01 | Female-biased |
| ESCA | ZC3H10 | exon_skip_285873 | 7.97e+00 | 9.87e-01 | 7.42e+00 | 4.43e-03 | Male-biased |
| READ | STAR-PAP | exon_skip_285854 | 1.36e+01 | 6.53e-04 | 1.41e+01 | 9.99e-01 | Female-biased |
| THCA | ESRP2 | exon_skip_285879 | 8.72e+00 | 9.82e-01 | 8.44e+00 | 1.29e-02 | Male-biased |
| PCPG | STAR-PAP | exon_skip_285854 | 1.45e+01 | 1.00e+00 | 1.39e+01 | 3.73e-04 | Male-biased |
| PCPG | ZC3H10 | exon_skip_285873 | 7.67e+00 | 9.89e-01 | 7.14e+00 | 9.79e-04 | Male-biased |
| LGG | HNRNPH2 | exon_skip_285882 | 6.90e+00 | 9.81e-01 | 6.48e+00 | 4.14e-03 | Male-biased |
| GBM | HNRNPH2 | exon_skip_285854 | 6.43e+00 | 9.81e-01 | 5.78e+00 | 4.44e-04 | Male-biased |
| PAAD | HNRNPH2 | exon_skip_285854 | 6.43e+00 | 9.81e-01 | 5.77e+00 | 1.47e-04 | Male-biased |
| KICH | ESRP2 | exon_skip_285879 | 8.40e+00 | 1.39e-02 | 8.70e+00 | 9.80e-01 | Female-biased |
| KICH | HNRNPH2 | exon_skip_285882 | 6.96e+00 | 9.82e-01 | 6.56e+00 | 4.29e-03 | Male-biased |
| KICH | STAR-PAP | exon_skip_285854 | 1.38e+01 | 1.09e-03 | 1.43e+01 | 9.99e-01 | Female-biased |
| SARC | STAR-PAP | exon_skip_285854 | 1.38e+01 | 3.55e-03 | 1.43e+01 | 9.96e-01 | Female-biased |
| SARC | ZC3H10 | exon_skip_285873 | 7.55e+00 | 9.83e-01 | 7.14e+00 | 6.31e-03 | Male-biased |
| CAMTA2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs78832980 | chr17:10846396:G:A | - | -0.0895607417923791 | 0.0380659941391743 | LUAD | Female-baised eQTL |
| rs7210598 | chr17:8947143:G:A | - | 0.104960458509925 | 0.0126753123305067 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4792594 | chr17:8217305:A:T | - | 0.0923817609029165 | 0.0297232771760225 | HNSC | Male-baised eQTL |
| rs443532 | chr17:8884178:G:A | - | 0.0651797955725595 | 0.00920932890319437 | KIRC | Male-baised eQTL |
| rs400439 | chr17:8882721:A:C | - | 0.0628182883576649 | 0.0136601857521868 | KIRC | Male-baised eQTL |
| rs375882 | chr17:8883303:T:C | - | 0.0644944689341436 | 0.0152622501341041 | KIRC | Male-baised eQTL |
| rs373480 | chr17:8882698:C:G | - | 0.063855464148507 | 0.0165483028433293 | KIRC | Male-baised eQTL |
| rs454347 | chr17:8884837:C:A | - | 0.0634922777408765 | 0.018676098747492 | KIRC | Male-baised eQTL |
| rs674858 | chr17:8883386:C:A | - | 0.0650792969829344 | 0.0201371381393501 | KIRC | Male-baised eQTL |
| rs436193 | chr17:8884530:G:C | - | 0.0628720629593679 | 0.0205120929193533 | KIRC | Male-baised eQTL |
| rs453692 | chr17:8883183:C:T | - | 0.0650448727585485 | 0.0210812702955664 | KIRC | Male-baised eQTL |
| rs454852 | chr17:8884121:C:T | - | 0.0625477336372861 | 0.0228657119835453 | KIRC | Male-baised eQTL |
| rs436384 | chr17:8884638:T:C | - | 0.0615024531783627 | 0.0271904504916428 | KIRC | Male-baised eQTL |
| rs2021844 | chr17:14422367:C:T | - | -0.0531693896499339 | 0.0280301216722376 | KIRC | Male-baised eQTL |
| rs373495 | chr17:8882679:C:A | - | 0.061081709634593 | 0.0299304414084901 | KIRC | Male-baised eQTL |
| rs4054654 | chr17:14421291:G:T | - | -0.0431282374363169 | 0.0347221738162565 | KIRC | Male-baised eQTL |
| rs2022234 | chr17:14422680:A:T | - | -0.0431641328582274 | 0.0347817370301695 | KIRC | Male-baised eQTL |
| rs12709307 | chr17:14420560:G:A | - | -0.0429219057027084 | 0.0423807852699437 | KIRC | Male-baised eQTL |
| rs2170368 | chr17:14422111:C:T | - | -0.0516281021076139 | 0.0425805309602664 | KIRC | Male-baised eQTL |
| rs2022236 | chr17:14422920:T:C | - | -0.0516281021076139 | 0.0425805309602664 | KIRC | Male-baised eQTL |
| rs4792482 | chr17:14423760:C:T | - | -0.0515595184786954 | 0.0444526865217619 | KIRC | Male-baised eQTL |
| rs12952654 | chr17:9973615:A:G | - | -0.0623996767970249 | 0.00870436169583053 | COAD | Male-baised eQTL |
| rs368117 | chr17:8593802:G:T | - | -0.0686066410766142 | 0.0322569033937139 | COAD | Male-baised eQTL |
| rs8067045 | chr17:8585696:G:A | - | -0.0664875167455109 | 0.0435623307193616 | COAD | Male-baised eQTL |
| rs2435960 | chr17:8593740:T:C | - | -0.0648748043679284 | 0.0476348064204722 | COAD | Male-baised eQTL |
| rs10048190 | chr17:8585100:C:T | - | -0.0657615189726821 | 0.0476420322894614 | COAD | Male-baised eQTL |
| rs1077119 | chr17:8586345:A:G | - | -0.0657615189726821 | 0.0476420322894614 | COAD | Male-baised eQTL |
| rs7212791 | chr17:8587932:C:T | - | -0.0657615189726821 | 0.0476420322894614 | COAD | Male-baised eQTL |
| rs10852901 | chr17:8588460:C:T | - | -0.0657615189726821 | 0.0476420322894614 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
 | EX ID: exon_skip_285847 |
| SNP ID: rs2439936 | |
| SNP Position to ES: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.187334516092023 | |
 | EX ID: exon_skip_285847 |
| SNP ID: rs2641252 | |
| SNP Position to ES: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.187408464077461 | |
 | EX ID: exon_skip_285847 |
| SNP ID: rs2585258 | |
| SNP Position to ES: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.187408464077461 | |
 | EX ID: exon_skip_285847 |
| SNP ID: rs2439933 | |
| SNP Position to ES: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.152456441259101 | |
 | EX ID: exon_skip_285847 |
| SNP ID: rs72827695 | |
| SNP Position to ES: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.119471175498339 |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs62073701 | chr17:5271500:T:C | Distant upstream | -0.0353252148635091 | 0.0395145310480394 | KIRC | Female-baised sQTL |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs11078555 | chr17:5276186:C:T | Distant upstream | -0.0353252148635091 | 0.0395145310480394 | KIRC | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs2439936 | chr17:5243175:G:T | Distant upstream | 0.187334516092023 | 5.40595247525294e-10 | BLCA | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs2641252 | chr17:5238813:A:C | Distant upstream | 0.187408464077461 | 5.50565729240796e-10 | BLCA | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs2585258 | chr17:5239761:C:T | Distant upstream | 0.187408464077461 | 5.50565729240796e-10 | BLCA | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs2439933 | chr17:5244209:G:T | Distant upstream | 0.152456441259101 | 4.54106679857526e-07 | BLCA | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs72827695 | chr17:5692258:G:C | Distant upstream | 0.119471175498339 | 6.37401131955094e-05 | BLCA | Female-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs72826578 | chr17:5755343:T:C | Distant upstream | 0.118980443801448 | 0.000141314097683562 | BLCA | Female-baised sQTL |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs2176324 | chr17:4040249:G:A | Distant downstream | 0.052467502042516 | 0.0215239919256848 | KIRP | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs72837972 | chr17:5864750:C:G | Distant upstream | -0.0488658684430561 | 0.022819127779632 | COAD | Male-baised sQTL |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs1468927 | chr17:5861805:G:A | Distant upstream | -0.0546891925752264 | 0.0269553520516158 | COAD | Male-baised sQTL |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs72837968 | chr17:5862085:G:A | Distant upstream | -0.0546891925752264 | 0.0269553520516158 | COAD | Male-baised sQTL |
| exon_skip_285873 | chr17:4982088:4982160 | In-frame | rs7210329 | chr17:5864351:G:A | Distant upstream | -0.0541937855555385 | 0.0298353813803062 | COAD | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs73974444 | chr17:5863712:G:A | Distant upstream | 0.051756999150754 | 0.0115003919177164 | BLCA | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs1004068 | chr17:5954995:G:C | Distant upstream | -0.25954887654321 | 0.000398200148392314 | PCPG | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62072179 | chr17:4145018:C:T | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs7208820 | chr17:4145799:G:T | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62072180 | chr17:4146301:G:T | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62072181 | chr17:4146515:C:T | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62072183 | chr17:4147886:C:T | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs34014959 | chr17:4148298:C:A | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs897027 | chr17:4148996:A:G | Distant downstream | 0.10670946020572 | 0.00413260086452708 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62072182 | chr17:4147554:A:C | Distant downstream | 0.105989543533382 | 0.00500439122130057 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs4790573 | chr17:4149675:T:G | Distant downstream | -0.103588015126991 | 0.00717305726020705 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs8066337 | chr17:4144787:T:C | Distant downstream | 0.102912576510369 | 0.00763985500813244 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs8080327 | chr17:4144447:A:G | Distant downstream | 0.102472753298134 | 0.0145939931939031 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs62071006 | chr17:4116617:A:T | Distant downstream | 0.117941855517529 | 0.0146475149258913 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs2054040 | chr17:4144912:G:A | Distant downstream | -0.0956853818942314 | 0.0181736590197381 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs11078483 | chr17:4146190:G:A | Distant downstream | -0.0956853818942314 | 0.0181736590197381 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs8076592 | chr17:4150649:C:G | Distant downstream | -0.0956853818942314 | 0.0181736590197381 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs9905832 | chr17:4065002:A:G | Distant downstream | 0.116326264253982 | 0.0193292169142225 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs3087605 | chr17:4157285:G:T | Distant downstream | 0.113788880031361 | 0.0259270691643717 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs9904222 | chr17:4153248:G:A | Distant downstream | 0.113748051572347 | 0.0267055110398838 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs4328477 | chr17:4108308:A:G | Distant downstream | 0.0987229774204697 | 0.0284387871869524 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs9908412 | chr17:4113417:C:T | Distant downstream | 0.112006546871789 | 0.0290703541064014 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs28407844 | chr17:4115445:T:C | Distant downstream | 0.112006546871789 | 0.0290703541064014 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs4790175 | chr17:4155043:G:A | Distant downstream | -0.0884889147292631 | 0.0400329179879296 | GBM | Male-baised sQTL |
| exon_skip_285847 | chr17:4969499:4969520 | In-frame | rs1006149 | chr17:4041984:A:G | Distant downstream | 0.0965202478447642 | 0.0442016824343066 | GBM | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
 | EX ID: exon_skip_285847 |
| CpG Site: cg15213988 | |
| Position to EX: Distant upstream | |
| Male Effect: - | |
| Female Effect: -0.407355720779385 | |
 | EX ID: exon_skip_285847 |
| CpG Site: cg27507261 | |
| Position to EX: Distant upstream | |
| Male Effect: - | |
| Female Effect: -0.407355720779385 | |
 | EX ID: exon_skip_285847 |
| CpG Site: cg15045292 | |
| Position to EX: Distant upstream | |
| Male Effect: - | |
| Female Effect: -0.407355720779385 | |
 | EX ID: exon_skip_285847 |
| CpG Site: cg01774335 | |
| Position to EX: Distant upstream | |
| Male Effect: -0.377122507753439 | |
| Female Effect: - |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_285847 | chr17:4969499:4969520 | cg01774335 | chr17:5385334 | Distant upstream | -0.377122507753439 | 6.58594596696053e-09 | -0.8695477585978079 | 1.2516937024723064e-29 | In-frame | PAAD |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_285847 | chr17:4969499:4969520 | cg15213988 | chr17:5093839 | Distant upstream | -0.407355720779385 | 8.48569607639301e-69 | -0.37164858928934075 | 0.00016468025074452356 | In-frame | BLCA |
| exon_skip_285847 | chr17:4969499:4969520 | cg27507261 | chr17:5499733 | Distant upstream | -0.407355720779385 | 8.48569607639301e-69 | -0.42765249717649173 | 1.1224524052651163e-05 | In-frame | BLCA |
| exon_skip_285847 | chr17:4969499:4969520 | cg15045292 | chr17:5499829 | Distant upstream | -0.407355720779385 | 8.48569607639301e-69 | -0.3985595466623383 | 4.810068010760308e-05 | In-frame | BLCA |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CAMTA2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
